Gut Microbiota Composition and Cardiovascular Disease : A Potential New Therapeutic Target?
A great deal of evidence has revealed an important link between gut microbiota and the heart. In particular, the gut microbiota plays a key role in the onset of cardiovascular (CV) disease, including heart failure (HF). In HF, splanchnic hypoperfusion causes intestinal ischemia resulting in the translocation of bacteria and their metabolites into the blood circulation. Among these metabolites, the most important is Trimethylamine N-Oxide (TMAO), which is responsible, through various mechanisms, for pathological processes in different organs and tissues. In this review, we summarise the complex interaction between gut microbiota and CV disease, particularly with respect to HF, and the possible strategies for influencing its composition and function. Finally, we highlight the potential role of TMAO as a novel prognostic marker and a new therapeutic target for HF.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
International journal of molecular sciences - 24(2023), 15 vom: 26. Juli |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Belli, Martina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Atherosclerosis |
|---|
| Anmerkungen: |
Date Completed 14.08.2023 Date Revised 14.08.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3390/ijms241511971 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360688586 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360688586 | ||
| 003 | DE-627 | ||
| 005 | 20231226083538.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/ijms241511971 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1202.xml |
| 035 | |a (DE-627)NLM360688586 | ||
| 035 | |a (NLM)37569352 | ||
| 035 | |a (PII)11971 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Belli, Martina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Gut Microbiota Composition and Cardiovascular Disease |b A Potential New Therapeutic Target? |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.08.2023 | ||
| 500 | |a Date Revised 14.08.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a A great deal of evidence has revealed an important link between gut microbiota and the heart. In particular, the gut microbiota plays a key role in the onset of cardiovascular (CV) disease, including heart failure (HF). In HF, splanchnic hypoperfusion causes intestinal ischemia resulting in the translocation of bacteria and their metabolites into the blood circulation. Among these metabolites, the most important is Trimethylamine N-Oxide (TMAO), which is responsible, through various mechanisms, for pathological processes in different organs and tissues. In this review, we summarise the complex interaction between gut microbiota and CV disease, particularly with respect to HF, and the possible strategies for influencing its composition and function. Finally, we highlight the potential role of TMAO as a novel prognostic marker and a new therapeutic target for HF | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a atherosclerosis | |
| 650 | 4 | |a cardiovascular diseases | |
| 650 | 4 | |a gut microbiota | |
| 650 | 4 | |a heart failure | |
| 650 | 4 | |a trimethylamine N-Oxide | |
| 650 | 7 | |a trimethyloxamine |2 NLM | |
| 650 | 7 | |a FLD0K1SJ1A |2 NLM | |
| 650 | 7 | |a Methylamines |2 NLM | |
| 700 | 1 | |a Barone, Lucy |e verfasserin |4 aut | |
| 700 | 1 | |a Longo, Susanna |e verfasserin |4 aut | |
| 700 | 1 | |a Prandi, Francesca Romana |e verfasserin |4 aut | |
| 700 | 1 | |a Lecis, Dalgisio |e verfasserin |4 aut | |
| 700 | 1 | |a Mollace, Rocco |e verfasserin |4 aut | |
| 700 | 1 | |a Margonato, Davide |e verfasserin |4 aut | |
| 700 | 1 | |a Muscoli, Saverio |e verfasserin |4 aut | |
| 700 | 1 | |a Sergi, Domenico |e verfasserin |4 aut | |
| 700 | 1 | |a Federici, Massimo |e verfasserin |4 aut | |
| 700 | 1 | |a Barillà, Francesco |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of molecular sciences |d 2008 |g 24(2023), 15 vom: 26. Juli |w (DE-627)NLM185552161 |x 1422-0067 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2023 |g number:15 |g day:26 |g month:07 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/ijms241511971 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2023 |e 15 |b 26 |c 07 | ||